. Fatty acid binding properties of M. globosa CYP5218. Absorbance difference spectra were measured during the progressive titration of 4 µM CYP5218 with the fatty acids C10:0 (capric acid), C12:0 (lauric acid), C14:0 (myristic acid), C16:0 (palmitic acid), C18:0 (stearic acid), C20:0 (arachidic acid), C12:1 (lauroleic acid), C14:1 (myristoleic acid), C16:1 (palmitoleic acid), C18:1 (oleic acid), C18:2 (linoleic acid) and C20:4 (arachidonic acid). The resultant type I difference spectra obtained for each fatty acid are shown. Each experiment was performed in triplicate although only one replicate is shown. Figure S2 . GC/MS analysis of lanosterol demethylation by CYP51. The GC trace for CYP51 metabolites using lanosterol as substrate and the mass fragmentation patterns for the TMSderivatized lanosterol (A -m/z 498) and C14-demethylated lanosterol (P -m/z 482) are shown. Figure S3 . GC/MS analysis of eburicol demethylation by CYP51. The GC trace for CYP51 metabolites using eburicol as substrate and the mass fragmentation patterns for the TMS-derivatized eburicol (B -m/z 512) and C14-demethylated eburicol (Q -m/z 496) are shown. Figure S4 . GC/MS analysis of obtusifoliol demethylation by CYP51. The GC trace for CYP51 metabolites using obtusifoliol as substrate and the mass fragmentation patterns for the TMSderivatized obtusifoliol (C -m/z 498) and C14-demethylated obtusifoliol (R -m/z 482) are shown. The temperature ramp gradient for the GC of obtusifoliol samples were five-times slower (5°C min -1 ) than for lanosterol and eburicol to aid separation of products. Each experiment was performed in triplicate although only one replicate is shown.
